Researchers at Northeastern University have identified two proteins abundant on drug-resistant ovarian cancer cells that become receptive to chemotherapy when treated with light.

Published in the journal Photochemistry and Photobiology, the research findings represent promising progress in the treatment of one of the most deadly forms of cancer. By targeting cancer cells with photo-sensitive antibodies and then shining light on them, researchers have made previously untreatable tumors receptive to drugs.

(This may be a repost, but still cool. Reposts are cool because it is a sign of something to pay attention to.)

Researchers have developed a light-based ovarian cancer therapy that makes tumors more receptive to chemotherapy.